UCLA partnered with Northeast Valley Health Corporation (NEVHC) to assess repeat FIT rates and factors that contribute to repeat FIT over a 5-year follow-up period. We performed a retrospective cohort […]
FORTE is a national colorectal cancer prevention study that aims to answer the following question: Should people who have small and benign colon polyps removed during colonoscopy have a repeat […]
This study utilizes a pragmatic, cluster randomized trial design within one of the largest FQHCs in the nation to test the effectiveness of a multilevel and multicomponent intervention (patient, provider, […]
The Community Collaboration to Advance Racial/Ethnic Equity in colorectal cancer (CRC) Screening (CARES) project aims to increase CRC screening rates in Community Health Centers (CHCs). CRC screening is underutilized, especially […]
Colorectal cancer (CRC) is a common and deadly disease that is largely preventable through the detection and removal of colon polyps. Over 1 million Americans are diagnosed with high-risk polyps […]
Cancer survivors diagnosed at an early age remain at risk for cancer recurrence and other chronic diseases. This study assessed engagement in surveillance for recurrence, cancer screening, and other recommended […]
Colorectal cancer (CRC) is a leading cause for cancer-related mortality in the United States (US), but screening is underutilized, especially in low-resource settings and among low income populations. The study […]
Colorectal cancer (CRC) is the second most common cause of cancer mortality in the U.S and screening is underutilized (62% U.S. rate in 2015). To address this issue, UCLA is partnering […]